Long-term treatment durability and safety after switching to bictegravir/emtricitabine/tenofovir alafenamide in real-world practice: a 144-week update from the BICTEL cohort. (linkinghub.elsevier.com)

Authors: Bortolani L … d'Ettorre G Journal: International Journal of Antimicrobial Agents Published: 2026-08-28 DOI: https://doi.org/10.1016/j.ijantimicag.2026.107991